Lee Scott Golden Sells $88K of PTC Therapeutics Inc (PTCT) — SEC Form 4, Feb 21, 2025

Open-Market Net Sale · SEC Form 4
−$88,045
10b5-1 Plan

Equity position changed by -2.2%

Reporting Owner
TXN 2025-02-20 · FILED 2025-02-21
Equity Position 76.9K sh 78,651 → 76,894
Equity Change -2.2% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2025-02-21
Report Date
2025-02-21
Accession No.
0001415889-25-005135
Accepted At
2025-02-21 22:20 UTC
Reporting Owner
Name Relationship
Lee Scott Golden CIK 0001686217
EVP
Lee Scott Golden at PTC Therapeutics Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $1,081,515
More from this insider at PTC Therapeutics Inc
2026-04-06 Sell -$56,364 View
2026-03-09 Sell -$633,800 View
2026-02-20 Sell -$172,290 View
2026-01-12 Sell -$66,206 View
2026-01-08 Sell -$152,855 View
All filings by this insider at PTC Therapeutics Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2025-02-19 S - Sale 10b5-1 795 D $50.10 -$39,826 77,856 Direct
Common StockF1 2025-02-20 S - Sale 10b5-1 962 D $50.12 -$48,219 76,894 Direct
Footnotes (1)
F1
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 5,000 RSUs from a February 15, 2024 grant of 20,000 RSUs and the vesting of 1,300 RSUs from a February 15, 2024 grant of 2,600 RSUs. Show more
5%+ Holders · 13D/G 5 filers
Other insiders at PTC Therapeutics Inc
All PTC Therapeutics Inc insider activity
GET /v1/forms/4/0001415889-25-005135 API docs
View Original SEC Filing